HU168859B - - Google Patents
Info
- Publication number
- HU168859B HU168859B HUSA2719A HUSA002719A HU168859B HU 168859 B HU168859 B HU 168859B HU SA2719 A HUSA2719 A HU SA2719A HU SA002719 A HUSA002719 A HU SA002719A HU 168859 B HU168859 B HU 168859B
- Authority
- HU
- Hungary
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1669873A CH587858A5 (US06826419-20041130-M00005.png) | 1973-11-28 | 1973-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU168859B true HU168859B (US06826419-20041130-M00005.png) | 1976-07-28 |
Family
ID=4419482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUSA2719A HU168859B (US06826419-20041130-M00005.png) | 1973-11-28 | 1974-11-26 |
Country Status (25)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH601321A5 (US06826419-20041130-M00005.png) * | 1975-01-06 | 1978-07-14 | Sandoz Ag | |
| CH619468A5 (US06826419-20041130-M00005.png) * | 1976-01-12 | 1980-09-30 | Sandoz Ag | |
| DE3020895A1 (de) * | 1979-06-12 | 1980-12-18 | Sandoz Ag | Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen |
| US5069911A (en) * | 1985-02-05 | 1991-12-03 | Sandoz Ltd. | Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
| US7771746B2 (en) * | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| GB0409785D0 (en) * | 2004-04-30 | 2004-06-09 | Resolution Chemicals Ltd | Preparation of cabergoline |
| GB0505965D0 (en) * | 2005-03-23 | 2005-04-27 | Resolution Chemicals Ltd | Preparation of cabergoline |
| US7339060B2 (en) | 2005-03-23 | 2008-03-04 | Resolution Chemicals, Ltd. | Preparation of cabergoline |
| US20070197576A1 (en) * | 2006-02-08 | 2007-08-23 | Resolution Chemicals Limited | Production of Cabergoline and Novel Polymorphic Form Thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2619488A (en) * | 1952-11-25 | Method of preparing d | ||
| DE1006425B (de) * | 1954-04-07 | 1957-04-18 | Sandoz Ag | Verfahren zur Herstellung der isomeren racemischen Dihydrolysergsaeuren und ihren Homologen |
| GB769260A (en) * | 1954-04-07 | 1957-03-06 | Sandoz Ltd | Process for the preparation of isomeric racemic dihydrolysergic acids and their homologues |
| GB1011112A (en) * | 1961-05-10 | 1965-11-24 | Sandoz Ag | Improvements in or relating to ergot alkaloids |
| CH469006A (de) * | 1965-07-07 | 1969-02-28 | Sandoz Ag | Verfahren zur Herstellung neuer synthetischer Alkaloide |
| CH469735A (de) * | 1965-11-02 | 1969-03-15 | Sandoz Ag | Verfahren zur Herstellung heterocyclischer Verbindungen |
| GB1298277A (en) * | 1969-04-18 | 1972-11-29 | Sandoz Ltd | Preparation of ergot peptide alkaloids |
| CH534683A (de) * | 1970-05-26 | 1973-03-15 | Sandoz Ag | Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide |
| CH601321A5 (US06826419-20041130-M00005.png) * | 1975-01-06 | 1978-07-14 | Sandoz Ag | |
| US4138565A (en) * | 1975-05-31 | 1979-02-06 | Sandoz Ltd. | Stable solutions and processes for their preparation |
-
1973
- 1973-11-28 CH CH1669873A patent/CH587858A5/xx not_active IP Right Cessation
-
1974
- 1974-11-18 DE DE19742454619 patent/DE2454619A1/de not_active Withdrawn
- 1974-11-19 DK DK600374A patent/DK143804C/da not_active IP Right Cessation
- 1974-11-19 FI FI3345/74A patent/FI59254C/fi active
- 1974-11-20 NO NO744175A patent/NO744175L/no unknown
- 1974-11-20 SE SE7414607A patent/SE417319B/xx unknown
- 1974-11-22 NL NL7415250A patent/NL7415250A/xx not_active Application Discontinuation
- 1974-11-25 GB GB50914/74A patent/GB1496491A/en not_active Expired
- 1974-11-25 GB GB23690/77A patent/GB1496492A/en not_active Expired
- 1974-11-26 DD DD182581A patent/DD115119A5/xx unknown
- 1974-11-26 CS CS8081A patent/CS176291B2/cs unknown
- 1974-11-26 IE IE2432/74A patent/IE41767B1/en unknown
- 1974-11-26 PH PH16563A patent/PH13669A/en unknown
- 1974-11-26 HU HUSA2719A patent/HU168859B/hu unknown
- 1974-11-26 AT AT945174A patent/AT352911B/de not_active IP Right Cessation
- 1974-11-26 IL IL46128A patent/IL46128A/en unknown
- 1974-11-26 ES ES432288A patent/ES432288A1/es not_active Expired
- 1974-11-27 CA CA214,716A patent/CA1034572A/en not_active Expired
- 1974-11-27 JP JP49135657A patent/JPS5919116B2/ja not_active Expired
- 1974-11-28 BE BE150971A patent/BE822729A/xx not_active IP Right Cessation
- 1974-11-28 SU SU2082566A patent/SU516355A3/ru active
- 1974-11-28 FR FR7439049A patent/FR2252098B1/fr not_active Expired
- 1974-11-28 ZA ZA00747603A patent/ZA747603B/xx unknown
-
1977
- 1977-01-31 FR FR7702636A patent/FR2334681A1/fr active Granted
- 1977-09-16 SE SE7710418A patent/SE424869B/xx unknown
-
1978
- 1978-06-29 US US05/920,480 patent/US4229451A/en not_active Expired - Lifetime
-
1980
- 1980-09-25 HK HK540/80A patent/HK54080A/xx unknown
-
1981
- 1981-12-30 MY MY185/81A patent/MY8100185A/xx unknown
